Related Content
May 19, 2015 — Abbott announced that it has received CE Mark for the latest advancement of its Absorb stent system ...
May 13, 2015 — Abbott and GE Healthcare announced an agreement that will bring real-time, patient-specific data about ...
March 20, 2015 —The commercial track record with transcatheter mitral valve repair, approved for patients at high risk ...
Ongoing clinical trials of bioresorbable stents continue to show positive data for the devices, which are widely ...
Nov. 11, 2014 — Viva Physicians, a not-for-profit organization in the field of vascular medicine and intervention ...
November 4, 2014 — The U.S. Food and Drug Administration (FDA) has cleared the Abbott family of Xience everolimus ...
There are several hemostasis devices that can help cath labs improve efficiency by reducing nursing time in the recovery ...
Oct. 29, 2014 – Abbott has entered into an agreement to purchase Topera Inc., a private, venture-backed medical device ...
October 27, 2014 – Annie Henderson, 69, suffers from multiple chronic ailments, including kidney failure and mitral ...
October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb ...